FRED ALGER MANAGEMENT, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 253 filers reported holding SAGE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
FRED ALGER MANAGEMENT, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$5,957,000
+264.8%
104,851
+380.7%
0.01%
+250.0%
Q1 2021$1,633,000
-54.9%
21,814
-47.9%
0.00%
-55.6%
Q4 2020$3,619,000
-59.9%
41,830
-71.7%
0.01%
-65.4%
Q3 2020$9,019,000
+1207.1%
147,568
+514.9%
0.03%
+1200.0%
Q1 2020$690,000
-36.3%
24,000
+60.0%
0.00%
-50.0%
Q4 2019$1,083,000
+2.9%
15,000
+100.0%
0.00%0.0%
Q3 2019$1,052,000
-17.9%
7,500
+7.1%
0.00%
-20.0%
Q2 2019$1,282,000
+34.4%
7,000
+16.7%
0.01%
+25.0%
Q1 2019$954,000
-66.2%
6,000
-70.0%
0.00%
-63.6%
Q3 2018$2,823,000
-23.1%
19,989
-14.8%
0.01%
-26.7%
Q2 2018$3,672,000
+18.8%
23,460
+22.3%
0.02%
+7.1%
Q1 2018$3,090,000
+188.5%
19,184
+195.1%
0.01%
+180.0%
Q4 2017$1,071,000
+71.6%
6,500
-35.1%
0.01%
+66.7%
Q3 2017$624,000
-13.0%
10,009
+11.1%
0.00%0.0%
Q2 2017$717,000
+26.0%
9,009
+12.6%
0.00%0.0%
Q1 2017$569,0008,0000.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Sio Capital Management, LLC 179,200$29,516,00016.65%
TRV GP II, LLC 547,916$90,247,00016.25%
Opus Point Partners Management, LLC 71,000$11,694,00010.12%
Casdin Capital, LLC 250,000$41,178,00010.03%
RA Capital Management 455,173$74,972,0006.27%
Crawford Lake Capital Management, LLC 154,278$25,411,0006.00%
Palo Alto Investors LP 810,806$133,548,0005.75%
GREAT POINT PARTNERS LLC 200,000$32,942,0005.62%
BB BIOTECH AG 1,042,439$171,700,0004.84%
Crawford Lake Capital Management, LLC 92,300$15,203,0003.59%
View complete list of SAGE THERAPEUTICS INC shareholders